WallStSmart

Coherent Inc (COHR)vsFocus Universal Inc (FCUV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coherent Inc generates 945737% more annual revenue ($7.12B vs $752,580). COHR leads profitability with a 11.3% profit margin vs 0.0%. COHR earns a higher WallStSmart Score of 62/100 (C+).

COHR

Buy

62

out of 100

Grade: C+

Growth: 9.3Profit: 5.5Value: 4.0Quality: 7.0
Piotroski: 5/9Altman Z: 1.90

FCUV

Avoid

33

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 6.0Quality: 4.5
Piotroski: 3/9Altman Z: -5.27
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COHRSignificantly Overvalued (-86.0%)

Margin of Safety

-86.0%

Fair Value

$164.21

Current Price

$305.37

$141.16 premium

UndervaluedFair: $164.21Overvalued
FCUVUndervalued (+15.6%)

Margin of Safety

+15.6%

Fair Value

$6.36

Current Price

$5.70

$0.66 discount

UndervaluedFair: $6.36Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COHR4 strengths · Avg: 9.3/10
Revenue GrowthGrowth
33.7%10/10

Revenue surging 33.7% year-over-year

EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

Market CapQuality
$57.41B9/10

Large-cap with strong market position

PEG RatioValuation
0.928/10

Growing faster than its price suggests

FCUV2 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
1811.0%10/10

Revenue surging 1811.0% year-over-year

Areas to Watch

COHR4 concerns · Avg: 2.8/10
Altman Z-ScoreHealth
1.904/10

Grey zone — moderate risk

Return on EquityProfitability
7.4%3/10

ROE of 7.4% — below average capital efficiency

P/E RatioValuation
71.0x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-493.40M2/10

Negative free cash flow — burning cash

FCUV4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$7.98M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Debt/EquityHealth
1.363/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : COHR

The strongest argument for COHR centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 33.7% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bull Case : FCUV

The strongest argument for FCUV centers on Price/Book, Revenue Growth. Revenue growth of 1811.0% demonstrates continued momentum.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, P/E Ratio. A P/E of 71.0x leaves little room for execution misses.

Bear Case : FCUV

The primary concerns for FCUV are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

COHR profiles as a growth stock while FCUV is a hypergrowth play — different risk/reward profiles.

COHR carries more volatility with a beta of 2.10 — expect wider price swings.

FCUV is growing revenue faster at 1811.0% — sustainability is the question.

FCUV generates stronger free cash flow (-7M), providing more financial flexibility.

Bottom Line

COHR scores higher overall (62/100 vs 33/100) and 33.7% revenue growth. FCUV offers better value entry with a 15.6% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

Focus Universal Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Focus Universal Inc. develops and manufactures smart instrumentation platforms and devices. The company is headquartered in Ontario, California.

Want to dig deeper into these stocks?